Asia-Pacific Americas Africa Europe Middle East

HANALL BIOPHARMA

Company Profile:

HANALL BIOPHARMA Company Introduction

Company Type: Manufacturer (medical Company)

HANALL BIOPHARMA is a South Korean medical company primarily engaged in the research, research, manufacturing, and commercialization of innovative medical items. According to research Founded in 1973, the company focuses on creating novel drugs to address unmet medical needs, particularly in areas such as immunology, ophthalmology, and oncology. They operate their own facilities to drug discovery, research, and production. Therefore, HANALL BIOPHARMA is a manufacturer, not a trading company. I've found that they're involved in the entire lifecycle of medical items from invention to market.

Enterprise Products

HANALL BIOPHARMA Products:

* SUSTIVA (Efavirenz)

* FORTEO (Teriparatide)

* REMICADE (Infliximab)

* GLARGIN (Insulin Glargine)

* NESP (Darbepoetin Alfa)

* ALLERGAN AESTHETICS (Botulinum Toxin, Dermal Fillers)

* Various Over-the-Counter (OTC) Products and Health Supplements

Business Registration Information:

Manager:

Seung-Wook Park

Phone:

No Data

E-mail:

ir@hanall.co.kr

Official Website:
Address:

5F, Hanwha Life Insurance Building, 470, Deokgogae-ro, Jungwon-gu, Seongnam-si, Gyeonggi-do, 13200, Republic of Korea

This content is from AI, the data and information provided is for reference only and is not applicable to investment and purchase decisions. If there is any incorrect information, please contact customer service to correct it.